Market Cap 39.92B
Revenue (ttm) 14.55B
Net Income (ttm) 2.20B
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 16.33
Profit Margin 15.11%
Debt to Equity Ratio 0.52
Volume 9,584,400
Avg Vol 8,620,992
Day's Range N/A - N/A
Shares Out 4.45B
Stochastic %K 31%
Beta 0.15
Analysts Sell
Price Target $12.39

Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides var...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 44 1932 959 500
Address:
The Heights, Building 5, First Floor, Weybridge, United Kingdom
CapitalMonk
CapitalMonk May. 4 at 2:54 PM
$HLN Price: $9.31 (-0.69%) Trend: Bullish Market Bias (7D): Sideways ⚖️ Expected Range: ±0.19% RSI: 36.5 | Momentum: Moderate Volume: -87.9% vs avg Volatility: 1.09% Support: $9.07 | Resistance: $9.95 Tools used: https://www.trade-ideas.com Code: INTERSTOCK25
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 13 at 6:11 PM
$HLN RSI: 50.88, MACD: -0.1150 Vol: 0.23, MA20: 9.88, MA50: 10.31 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
CapitalMonk
CapitalMonk Apr. 8 at 2:26 PM
$HLN Price: $10.00 (+1.21%) Trend: Bullish Market Bias (7D): Sideways ⚖️ Expected Range: ±0.84% RSI: 36.8 | Momentum: Moderate Volume: -79.0% vs avg Volatility: 1.59% Support: $9.65 | Resistance: $10.64 Tools used: https://www.trade-ideas.com Code: INTERSTOCK25
0 · Reply
Bazzzigar
Bazzzigar Mar. 10 at 10:40 PM
$HLN HIMS
0 · Reply
DailyAnalysis
DailyAnalysis Feb. 25 at 10:39 PM
$HLN exhibits 1W trend strength as major stake sales clear. 1D RSI is resetting while 4H STOCH shows a bullish crossover. 30M CCI confirms buyer interest making this a classic consolidation play for a breakout. @DailyAnalysis
0 · Reply
stalkerjude
stalkerjude Feb. 20 at 4:15 PM
$HLN Haleon operates consumer healthcare brands. Cash flows are stable with modest growth. Pricing power supports margins.
0 · Reply
mohamettarik
mohamettarik Feb. 18 at 10:42 AM
$HLN lesson number 1 , dont buy on top....
0 · Reply
CoachHendo
CoachHendo Feb. 18 at 9:27 AM
$HLN ohh what a gap to fill! LT!
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 5 at 4:49 PM
$HLN RSI: 83.03, MACD: 0.2063 Vol: 0.33, MA20: 10.24, MA50: 9.99 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
ivyjCampb03
ivyjCampb03 Jan. 25 at 5:17 PM
$HLN Defensive structure holding support. Trend stabilizing. Needs breakout.
0 · Reply
Latest News on HLN
Haleon Earnings Call Transcript: Q1 2026

Apr 29, 2026, 4:00 AM EDT - 14 days ago

Haleon Earnings Call Transcript: Q1 2026


Haleon launches ‘For the Assist’ campaign

2026-04-28T11:32:33.000Z - 15 days ago

Haleon launches ‘For the Assist’ campaign


Haleon appoints Richard Manso as U.S. CMO

2026-04-27T14:32:33.000Z - 16 days ago

Haleon appoints Richard Manso as U.S. CMO


Haleon price target raised to 512 GBp from 510 GBp at Berenberg

2026-03-17T17:41:56.000Z - 2 months ago

Haleon price target raised to 512 GBp from 510 GBp at Berenberg


Haleon Earnings Call Transcript: H2 2025

Feb 25, 2026, 3:45 AM EST - 2 months ago

Haleon Earnings Call Transcript: H2 2025


Haleon Earnings Call Transcript: H2 2025

Feb 25, 2026, 2:00 AM EST - 2 months ago

Haleon Earnings Call Transcript: H2 2025


Haleon upgraded to Overweight from Equal Weight at Barclays

2026-01-23T09:40:44.000Z - 3 months ago

Haleon upgraded to Overweight from Equal Weight at Barclays


Haleon upgraded to Buy from Hold at HSBC

2026-01-21T10:05:21.000Z - 4 months ago

Haleon upgraded to Buy from Hold at HSBC


Haleon price target raised to 450 GBp from 440 GBp at Jefferies

2026-01-20T11:45:49.000Z - 4 months ago

Haleon price target raised to 450 GBp from 440 GBp at Jefferies


Haleon downgraded to Sell from Hold at Deutsche Bank

2026-01-12T10:45:29.000Z - 4 months ago

Haleon downgraded to Sell from Hold at Deutsche Bank


Haleon added to European Conviction List at Goldman Sachs

2026-01-05T09:25:06.000Z - 4 months ago

Haleon added to European Conviction List at Goldman Sachs


Haleon price target raised to 517 GBp from 507 GBp at Berenberg

2025-11-07T19:10:36.000Z - 6 months ago

Haleon price target raised to 517 GBp from 507 GBp at Berenberg


Haleon Earnings Call Transcript: Q3 2025

Oct 30, 2025, 5:00 AM EDT - 6 months ago

Haleon Earnings Call Transcript: Q3 2025


Haleon price target raised to 507 GBp from 500 GBp at Berenberg

2025-10-10T16:30:29.000Z - 7 months ago

Haleon price target raised to 507 GBp from 500 GBp at Berenberg


Haleon downgraded to Equal Weight from Overweight at Barclays

2025-09-16T09:15:13.000Z - 8 months ago

Haleon downgraded to Equal Weight from Overweight at Barclays


Haleon upgraded to Buy from Neutral at Goldman Sachs

2025-09-10T08:30:19.000Z - 8 months ago

Haleon upgraded to Buy from Neutral at Goldman Sachs


Haleon CEO: 'Quite optimistic about emerging market growth'

Jul 31, 2025, 4:53 AM EDT - 10 months ago

Haleon CEO: 'Quite optimistic about emerging market growth'

HLN


Haleon Earnings Call Transcript: H1 2025

Jul 31, 2025, 4:30 AM EDT - 10 months ago

Haleon Earnings Call Transcript: H1 2025


UK's Haleon cuts annual organic revenue growth forecast

Jul 31, 2025, 2:26 AM EDT - 10 months ago

UK's Haleon cuts annual organic revenue growth forecast

HLN


Haleon price target lowered to 450 GBp from 475 GBp at Barclays

2025-07-08T17:30:47.000Z - 11 months ago

Haleon price target lowered to 450 GBp from 475 GBp at Barclays

HLN


HALEON APPOINTS CARL HANEY AS CHIEF R&D OFFICER

Jun 24, 2025, 8:00 AM EDT - 11 months ago

HALEON APPOINTS CARL HANEY AS CHIEF R&D OFFICER

HLN


Haleon Transcript: CMD 2025

May 1, 2025, 8:00 AM EDT - 1 year ago

Haleon Transcript: CMD 2025


Pfizer sells entire Haleon stake for $3.24 billion

Mar 19, 2025, 3:26 AM EDT - 1 year ago

Pfizer sells entire Haleon stake for $3.24 billion

PFE


Pfizer to dispose of entire Haleon stake

Mar 18, 2025, 12:54 PM EDT - 1 year ago

Pfizer to dispose of entire Haleon stake

PFE


Haleon CEO: We're relatively low-exposed to tariffs

Feb 27, 2025, 10:30 AM EST - 1 year ago

Haleon CEO: We're relatively low-exposed to tariffs


Pfizer Sells 700 Million Haleon Shares for $3 Billion

Jan 15, 2025, 2:57 AM EST - 1 year ago

Pfizer Sells 700 Million Haleon Shares for $3 Billion

PFE


Haleon Pakistan to manufacture Centrum multivitamins

Dec 12, 2024, 4:31 AM EST - 1 year ago

Haleon Pakistan to manufacture Centrum multivitamins


Haleon reports marginal decline in third-quarter revenue

Oct 31, 2024, 3:21 AM EDT - 1 year ago

Haleon reports marginal decline in third-quarter revenue


Is the Haleon share price in trouble ahead of earnings?

Oct 30, 2024, 4:02 AM EDT - 1 year ago

Is the Haleon share price in trouble ahead of earnings?


Pfizer offloads $3.3 bln stake in Sensodyne-maker Haleon

Oct 1, 2024, 2:13 AM EDT - 1 year ago

Pfizer offloads $3.3 bln stake in Sensodyne-maker Haleon

PFE


Sensodyne maker Haleon to raise stake in China JV

Sep 27, 2024, 5:11 AM EDT - 1 year ago

Sensodyne maker Haleon to raise stake in China JV


GSK intends to sell its remaining stake in Haleon

May 16, 2024, 12:33 PM EDT - 2 years ago

GSK intends to sell its remaining stake in Haleon

GSK


Haleon's first-quarter revenue misses expectations

May 1, 2024, 3:00 AM EDT - 2 years ago

Haleon's first-quarter revenue misses expectations


Pfizer to Raise Around $4.27 Billion From Haleon Shares Sale

Mar 19, 2024, 6:47 AM EDT - 2 years ago

Pfizer to Raise Around $4.27 Billion From Haleon Shares Sale

PFE


CapitalMonk
CapitalMonk May. 4 at 2:54 PM
$HLN Price: $9.31 (-0.69%) Trend: Bullish Market Bias (7D): Sideways ⚖️ Expected Range: ±0.19% RSI: 36.5 | Momentum: Moderate Volume: -87.9% vs avg Volatility: 1.09% Support: $9.07 | Resistance: $9.95 Tools used: https://www.trade-ideas.com Code: INTERSTOCK25
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 13 at 6:11 PM
$HLN RSI: 50.88, MACD: -0.1150 Vol: 0.23, MA20: 9.88, MA50: 10.31 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
CapitalMonk
CapitalMonk Apr. 8 at 2:26 PM
$HLN Price: $10.00 (+1.21%) Trend: Bullish Market Bias (7D): Sideways ⚖️ Expected Range: ±0.84% RSI: 36.8 | Momentum: Moderate Volume: -79.0% vs avg Volatility: 1.59% Support: $9.65 | Resistance: $10.64 Tools used: https://www.trade-ideas.com Code: INTERSTOCK25
0 · Reply
Bazzzigar
Bazzzigar Mar. 10 at 10:40 PM
$HLN HIMS
0 · Reply
DailyAnalysis
DailyAnalysis Feb. 25 at 10:39 PM
$HLN exhibits 1W trend strength as major stake sales clear. 1D RSI is resetting while 4H STOCH shows a bullish crossover. 30M CCI confirms buyer interest making this a classic consolidation play for a breakout. @DailyAnalysis
0 · Reply
stalkerjude
stalkerjude Feb. 20 at 4:15 PM
$HLN Haleon operates consumer healthcare brands. Cash flows are stable with modest growth. Pricing power supports margins.
0 · Reply
mohamettarik
mohamettarik Feb. 18 at 10:42 AM
$HLN lesson number 1 , dont buy on top....
0 · Reply
CoachHendo
CoachHendo Feb. 18 at 9:27 AM
$HLN ohh what a gap to fill! LT!
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 5 at 4:49 PM
$HLN RSI: 83.03, MACD: 0.2063 Vol: 0.33, MA20: 10.24, MA50: 9.99 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
ivyjCampb03
ivyjCampb03 Jan. 25 at 5:17 PM
$HLN Defensive structure holding support. Trend stabilizing. Needs breakout.
0 · Reply
CleanSheetCap
CleanSheetCap Dec. 25 at 4:56 AM
$HLN Structural upside remains conditional on management’s ability to convert scale into defensible margin expansion, with outcomes shaped by timing and discipline. Evidence of traction would justify structural re‑rating.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 17 at 5:16 PM
$HLN RSI: 55.38, MACD: 0.0616 Vol: 0.17, MA20: 9.65, MA50: 9.47 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
TonySuprano
TonySuprano Dec. 16 at 8:33 PM
0 · Reply
TonySuprano
TonySuprano Dec. 16 at 8:33 PM
0 · Reply
TonySuprano
TonySuprano Dec. 16 at 8:33 PM
0 · Reply
TonySuprano
TonySuprano Dec. 16 at 8:30 PM
0 · Reply
TonySuprano
TonySuprano Dec. 16 at 8:30 PM
0 · Reply
TonySuprano
TonySuprano Dec. 16 at 8:30 PM
0 · Reply
TonySuprano
TonySuprano Dec. 16 at 8:30 PM
0 · Reply